<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BMC Ophthalmology - Most viewed articles</title>
		<link>http://www.biomedcentral.com/bmcophthalmol/mostviewed/</link>
		<description>Most viewed articles in last 30 days from BMC Ophthalmology (ISSN 1471-2415) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
         <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2415/8/9"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2415/8/15"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2415/8/8"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2415/8/10"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2415/8/14"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2415/8/5"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2415/8/7"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2415/7/3"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2415/6/29"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2415/8/13"/>			    
            
            </rdf:Seq>
        </items>
    </channel>
    
		<item rdf:about="http://www.biomedcentral.com/1471-2415/8/9">
            
            <title>Effectiveness of mobile-phone short message service (SMS) reminders for ophthalmology outpatient appointments: Observational study</title>
			<description>Background:
Non-attendance for hospital outpatient appointments is a significant problem in many countries. It causes suboptimal use of clinical and administrative staff and financial losses, as well as longer waiting times. The use of Short Message Service (SMS) appointment reminders potentially offers a cost-effective and time-efficient strategy to decrease non-attendance and so improve the efficiency of outpatient healthcare delivery.
Methods:
An SMS text message was sent to patients with scheduled appointments between April and September 2006 in a hospital ophthalmology department in London, reminding them of their appointments. This group acted as the intervention group. Controls were patients with scheduled ophthalmology appointments who did not receive an SMS or any alternative reminder.
Results:
During the period of the study, 11.2% (50/447) of patients who received an SMS appointment reminder were non-attenders, compared to 18.1% (1720/9512) who did not receive an SMS reminder. Non-attendance rates were 38% lower in patients who received an SMS reminder than in patients who did not receive a reminder (RR of non-attendance = 0.62; 95% CI = 0.48 &#8211; 0.80).
Conclusion:
The use of SMS reminders for ophthalmology outpatient appointments was associated with a reduction of 38% in the likelihood of patients not attending their appointments, compared to no appointment reminder. The use of SMS reminders may also be more cost-effective than traditional appointment reminders and require less labour. These findings should be confirmed with a more rigorous study design before a wider roll-out.</description>
			<link>http://www.biomedcentral.com/1471-2415/8/9</link>		
			<dc:creator>Elizabeth Koshy, Josip Car and Azeem Majeed</dc:creator>
			<dc:source>BMC Ophthalmology 2008, 8:9</dc:source>
			<dc:subject>Number of accesses: 408</dc:subject>
			<dc:date>2008-05-31</dc:date>
			<dc:identifier>doi:10.1186/1471-2415-8-9</dc:identifier>
			
			
							
					<prism:publicationName>BMC Ophthalmology</prism:publicationName>
					
			
							
					<prism:issn>1471-2415</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>9</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-31</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2415/8/15">
            
            <title>The ChromaTest, a digital color contrast sensitivity analyzer, for diabetic maculopathy: a pilot study</title>
			<description>Background:
To assess the ability of the Chromatest in investigating diabetic maculopathy.MethodPatients with Type 2 diabetes and no concurrent ocular pathology or previous laser photocoagulation were recruited. Visual acuities were assessed followed by colour contrast sensitivity testing of each eye using Chromatest. Dilated fundoscopy with slit lamp biomicroscopy with 78 D lens was then performed to confirm the stage of diabetic retinopathy according to the Early Treatment Diabetic Retinopathy Study.
Results:
150 eyes in 150 patients were recruited into this study. 35 eyes with no previous laser photocoagulation were shown to have clinically significant macular oedema (CSMO) and 115 eyes with untreated non-proliferative diabetic retinopathy (NPDR) on fundus biomicroscopy. Statistical significant difference was found between CSMO and NPDR eyes for protan colour contrast threshold (p = 0.01). Statistical significance was found between CSMO and NPDR eyes for tritan colour contrast threshold (p = 0.0002). Sensitivity and specificity for screening of CSMO using pass-fail criterion for age matched TCCT results achieved 71% (95% confidence interval: 53&#8211;85%) and 70% (95% confidence interval: 60&#8211;78%), respectively. However, threshold levels were derived using the same data set for both training and testing the effectiveness since this was the first study of NPDR using the Chromatest
Conclusion:
The ChromaTest is a simple, cheap, easy to use, and quick test for colour contrast sensitivity. This study did not achieve results to justify use of the Chromatest for screening, but it reinforced the changes seen in tritan colour vision in diabetic retinopathy.</description>
			<link>http://www.biomedcentral.com/1471-2415/8/15</link>		
			<dc:creator>Roger Wong, Jaheed Khan, Temi Adewoyin, Sobha Sivaprasad, Geoffrey B Arden and Victor Chong</dc:creator>
			<dc:source>BMC Ophthalmology 2008, 8:15</dc:source>
			<dc:subject>Number of accesses: 375</dc:subject>
			<dc:date>2008-08-17</dc:date>
			<dc:identifier>doi:10.1186/1471-2415-8-15</dc:identifier>
			
			
							
					<prism:publicationName>BMC Ophthalmology</prism:publicationName>
					
			
							
					<prism:issn>1471-2415</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>15</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-17</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2415/8/8">
            
            <title>Rotational stability of the AcrySof SA60TT toric intraocular lenses: A cohort study</title>
			<description>Background:
To evaluate the rotational stability of the three types of AcrySof SA60TT toric intraocular lenses (Alcon, Switzerland) in cataract surgery after the first postoperative week.
Methods:
A retrospective study of 44 eyes in 33 patients. All patients underwent similar uncomplicated phacoemulsification cataract surgery. Seven eyes with corneal astigmatism of less than 1.5 D were implanted with the AcrySof SA60T3 intraocular lens. Seventeen eyes with astigmatism between 1.5 D and 2.25 D received the SA60T4 intraocular lens, and 20 eyes with more than 2.25 D of corneal astigmatism received the SA60T5 intraocular lens. Intraoperatively, the axis of the toric lens was aligned to the steepest axis of the corneal astigmatism. Main outcome measure was the postoperative position of the lens, assessed at 1 week and 3 months, using a specially designed angle measuring eyepiece for the slit lamp.
Results:
There was no significant difference in the rotational stability of the three types of toric intraocular lenses. Overall, the postoperative rotation was within 5 degrees in 95% and within 2 degrees in 68% of eyes. The mean absolute rotation was 2.2 &#177; 2.2 degrees. No lens showed more than 9 degrees of rotation, and no lens required secondary repositioning. There was no trend for either clockwise or anti-clockwise rotation. The surgical procedure did not change the corneal astigmatism.
Conclusion:
Once placed to it's position, each of the three types of the AcrySof SA60TT toric intraocular lenses demonstrate rotational stability in the capsular bag.</description>
			<link>http://www.biomedcentral.com/1471-2415/8/8</link>		
			<dc:creator>Bruno Zuberbuhler, Theo Signer, Richard Gale and Eduard Haefliger</dc:creator>
			<dc:source>BMC Ophthalmology 2008, 8:8</dc:source>
			<dc:subject>Number of accesses: 309</dc:subject>
			<dc:date>2008-05-06</dc:date>
			<dc:identifier>doi:10.1186/1471-2415-8-8</dc:identifier>
			
			
							
					<prism:publicationName>BMC Ophthalmology</prism:publicationName>
					
			
							
					<prism:issn>1471-2415</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>8</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-06</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2415/8/10">
            
            <title>Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients</title>
			<description>Background:
This study was performed to assess the prevalence of dry eye syndrome and diabetic retinopathy (DR) in type 2 diabetic patients and their contributing factors.
Methods:
199 type 2 diabetic patients referred to Yazd Diabetes Research Center were consecutively selected. All Subjects were assessed by questionnaire about other diseases and drugs. Dry eye syndrome was assessed with Tear break up time tests and Schirmer. All the subjects underwent indirect ophthalmoscopy and retinal color photography. DR was graded according to early Treatment Diabetic Retinopathy (ETDRS) criteria.
Results:
Of 199 subjects, 108 patients (54.3%) suffer from dry eye syndrome. Although dry eye syndrome was more common in older and female patients, this association was not significant. But there was significantly association between dry eye syndrome and duration of diabetes (P = 0.01). Dry eye syndrome was more frequent in diabetic patients with DR (P = 0.02). DR was found in 140 patients (70.35%), which included 34 patients (17.1%) with mild non proliferative DR (NPDR), 34 patients (17.1%) with moderate NPDR, 22 patients (11.1%) with severe NPDR and 25 patients (25.1%) with proliferative DR (PDR). There were significant relation between age, sex and duration of diabetes and DR.
Conclusion:
In this study the prevalence of dry eye syndrome was 54.3%. Diabetes and dry eyes appear to have a common association. Further studies need to be undertaken to establish an etiologic relationship. However, examination for dry eye should be an integral part of the assessment of diabetic eye disease.</description>
			<link>http://www.biomedcentral.com/1471-2415/8/10</link>		
			<dc:creator>Masoud Reza Manaviat, Maryam Rashidi, Mohammad Afkhami-Ardekani and Mohammad Reza Shoja</dc:creator>
			<dc:source>BMC Ophthalmology 2008, 8:10</dc:source>
			<dc:subject>Number of accesses: 308</dc:subject>
			<dc:date>2008-06-02</dc:date>
			<dc:identifier>doi:10.1186/1471-2415-8-10</dc:identifier>
			
			
							
					<prism:publicationName>BMC Ophthalmology</prism:publicationName>
					
			
							
					<prism:issn>1471-2415</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>10</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-02</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2415/8/14">
            
            <title>Tono-Pen XL tonometry during application of a suction ring in rabbits</title>
			<description>Background:
The purpose of this study is to evaluate the use of Tono-Pen XL in measuring IOP during the application of a suction ring in rabbit eyes with manometrically controlled IOP.
Methods:
Tono-Pen XL was calibrated against direct manometry in 10 rabbit eyes. A suction ring was then applied in 4 rabbit eyes and the IOP was determined manometrically during suction ring application at 350 mmHg vacuum pressure. Finally, in 6 catheterized rabbit eyes the IOP was measured with Tono-Pen XL during suction ring application at suction vacuum from 350 to 650 mmHg, while keeping actual IOP stable at 30 mmHg and 60 mmHg.
Results:
Linear regression analysis revealed that the Tono-pen XL was reliable for IOPs between 10 and 70 mmHg (R2 = 0.9855). Direct manometry during suction ring application showed no statistically significant variation of Tono-Pen XL readings when the incanulation manometry intraocular pressure changed from 30 mmHg to 60 mmHg and no statistically significant correlation between suction vacuum and IOP measurements.
Conclusion:
Tono-Pen XL measurements are unreliable during the application of a suction ring on living rabbit eyes even when the actual IOP is forced to be within the validated range of Tono-Pen XL measurements. This inaccuracy is probably related to altered corneal and scleral geometry and stress.</description>
			<link>http://www.biomedcentral.com/1471-2415/8/14</link>		
			<dc:creator>Spyridon K Charisis, Harilaos S Ginis, Georgios A Kounis and Miltiadis K Tsilimbaris</dc:creator>
			<dc:source>BMC Ophthalmology 2008, 8:14</dc:source>
			<dc:subject>Number of accesses: 291</dc:subject>
			<dc:date>2008-07-30</dc:date>
			<dc:identifier>doi:10.1186/1471-2415-8-14</dc:identifier>
			
			
							
					<prism:publicationName>BMC Ophthalmology</prism:publicationName>
					
			
							
					<prism:issn>1471-2415</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>14</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-30</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2415/8/5">
            
            <title>Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema</title>
			<description>Background:
To assess the efficacy of the intravitreal (IVT) injection of Triamcinolone Acetonide (TA) as compared to posterior subtenon (SBT) capsule injection for the treatment of cystoid diabetic macular edema.
Methods:
Fourteen patients with type II diabetes mellitus and on insulin treatment, presenting diffuse cystoid macular edema were recruited. Before TA injection all focal lakes were treated by laser photocoagulation. In the same patients one eye was assigned to 4 mg IVT injection of TA and the fellow eye was then treated with 40 mg SBT injection of TA. Before and one, three and six months after treatment we measured visual acuity with ETDRS chart as well as thickness of the macula with optical coherence tomography (OCT) and intraocular pressure (IOP).
Results:
The eyes treated with an IVT injection displayed significant improvement in visual acuity, both after one (0.491 &#177; 0.070; p &lt; 0.001) and three months (0.500 &#177; 0.089; p &lt; 0.001) of treatment. Significant improvement was displayed also in eyes treated with an SBT injection, again after one (0.455 &#177; 0.069; p &lt; 0.001) and three months (0.427 &#177; 0.065; p &lt; 0.001). The difference between an IVT injection (0.809 &#177; 0.083) and SBT injection (0.460 &#177; 0.072) becomes significant six months after the treatment (p &lt; 0.001).Macular thickness of the eyes treated with IVT injection was significantly reduced both after one (222.7 &#177; 13.4 &#956;m; p &lt; 0.001) and after three months (228.1 &#177; 10.6 &#956;m; p &lt; 0.001) of treatment. The eyes treated with SBT injection displayed significant improvement after one (220.1 &#177; 15.1 &#956;m; p &lt; 0.001) and after three months (231.3 &#177; 10.9 &#956;m; p &lt; 0.001). The difference between the eyes treated with IVT injection (385.2 &#177; 11.3 &#956;m) and those treated with SBT injection (235.4 &#177; 8.7 &#956;m) becomes significant six months after the treatment (p &lt; 0.001).Intraocular pressure of the eyes treated with IVT injection significantly increased after one month (17.7 &#177; 1.1 mm/Hg; p &lt; 0.020), three (18.2 &#177; 1.2 mm/Hg; p &lt; 0.003) and six month (18.1 &#177; 1.3 mm/Hg; p &lt; 0.007) when compared to baseline value (16.1 &#177; 1.402 mm/Hg). In the SBT injection eyes we didn't display a significant increase of intraocular pressure after one (16.4 &#177; 1.2 mm/Hg; p &lt; 0.450), three (16.3 &#177; 1.1 mm/Hg; p &lt; 0.630) and six months (16.2 &#177; 1.1 mm/Hg; p &lt; 0.720) when compared to baseline value (16.2 &#177; 1.3 mm/Hg).
Conclusion:
The parabulbar subtenon approach can be considered a valid alternative to the intravitreal injection.Trial registrationCurrent Controlled Trials ISRCTN67086909</description>
			<link>http://www.biomedcentral.com/1471-2415/8/5</link>		
			<dc:creator>Mauro Cellini, Alberto Pazzaglia, Eugenio Zamparini, Pietro Leonetti and Emilio C Campos</dc:creator>
			<dc:source>BMC Ophthalmology 2008, 8:5</dc:source>
			<dc:subject>Number of accesses: 288</dc:subject>
			<dc:date>2008-03-17</dc:date>
			<dc:identifier>doi:10.1186/1471-2415-8-5</dc:identifier>
			
			
							
					<prism:publicationName>BMC Ophthalmology</prism:publicationName>
					
			
							
					<prism:issn>1471-2415</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>5</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-17</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2415/8/7">
            
            <title>Specific detection of fungal pathogens by 18S rRNA gene PCR in microbial keratitis</title>
			<description>Background:
The sensitivity and specificity of 18S rRNA polymerase chain reaction (PCR) in the detection of fungal aetiology of microbial keratitis was determined in thirty patients with clinical diagnosis of microbial keratitis.
Methods:
Corneal scrapings from patients were used for Gram stain, culture and PCR analysis. PCR was performed with primer pairs targeted to the 18S rRNA gene. The result of the PCR was compared with conventional culture and Gram staining method. The PCR positive samples were identified by DNA sequencing of the internal transcribed spacer (ITS) region of the rRNA gene. Main outcome measures were sensitivity and specificity of PCR in the detection of fungus in corneal keratitis.
Results:
Combination of microscopy and culture gave a positive result in 11 of 30 samples of microbial keratitis. PCR detected 10 of 11 samples that were positive by conventional method. One of the 19 samples that was negative by conventional method was positive by PCR. Statistical analysis revealed that the PCR to have a sensitivity of 90.9% and specificity of 94.7% in the detection of a fungal aetiology in microbial keratitis.
Conclusion:
PCR is a rapid, sensitive and useful method to detect fungal aetiology in microbial keratitis.</description>
			<link>http://www.biomedcentral.com/1471-2415/8/7</link>		
			<dc:creator>Zunaina Embong, Wan Hazabbah Wan Hitam, Chan Yean Yean, Nur Haslindawaty Abdul Rashid, Balqis Kamarudin, Siti Khaironi Zainal Abidin, Sabariah Osman, Zainul F Zainuddin and Manickam Ravichandran</dc:creator>
			<dc:source>BMC Ophthalmology 2008, 8:7</dc:source>
			<dc:subject>Number of accesses: 240</dc:subject>
			<dc:date>2008-04-29</dc:date>
			<dc:identifier>doi:10.1186/1471-2415-8-7</dc:identifier>
			
			
							
					<prism:publicationName>BMC Ophthalmology</prism:publicationName>
					
			
							
					<prism:issn>1471-2415</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>7</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2415/7/3">
            
            <title>TOZAL Study: An open case control study of an oral antioxidant and omega-3 supplement for dry AMD</title>
			<description>Background:
The primary objective of this prospective study was to measure the change from baseline in visual function &#8211; Best-Corrected Visual Acuity (BCVA) via the Early Treatment Diabetic Retinopathy Study (ETDRS) chart, contrast sensitivity, central 10 degree visual fields and retinal imaging (angiograms and photographs) at 6 months in subjects with atrophic (dry) age-related macular degeneration treated with a targeted nutritional supplement.
Methods:
37 mixed gender patients with a mean age of 76.3 +/- 7.8 years were enrolled at 5 independent study sites and received standard of care with a novel formulation of a nutritional supplement. Results were compared to a placebo cohort constructed from the literature that was matched for inclusion and exclusion criteria. A paired t-test was used to test a null hypothesis and a two-sided alpha level of 0.05 was used to determine statistical significance.
Results:
76.7% of subjects receiving the nutritional supplement demonstrated stabilization or improvement of BCVA at 6 months. Subjects gained an average of 0.0541 logMAR or one-half of a line of visual acuity (VA) over the 6-month period. There was a statistically significant improvement in VA from baseline with P = .045. The results provide strong evidence that the treatment being studied produces an improvement in VA.
Conclusion:
Treatment with this unique nutritional supplement increased VA above the expected baseline decrease in the majority of patients in this population with dry macular degeneration. The results of the TOZAL study agree with the LAST and CARMIS studies and are predictive for positive visual acuity outcomes in the AREDS II trial. However, patients will likely require supplementation for longer than 6 months to effect changes in additional visual parameters.</description>
			<link>http://www.biomedcentral.com/1471-2415/7/3</link>		
			<dc:creator>Francis E Cangemi</dc:creator>
			<dc:source>BMC Ophthalmology 2007, 7:3</dc:source>
			<dc:subject>Number of accesses: 208</dc:subject>
			<dc:date>2007-02-26</dc:date>
			<dc:identifier>doi:10.1186/1471-2415-7-3</dc:identifier>
			
			
							
					<prism:publicationName>BMC Ophthalmology</prism:publicationName>
					
			
							
					<prism:issn>1471-2415</prism:issn>
					
			
							
					<prism:volume>7</prism:volume>
					
			
							
					<prism:startingPage>3</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-02-26</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2415/6/29">
            
            <title>Bilateral acute angle closure glaucoma as a presentation of isolated microspherophakia in an adult: case report</title>
			<description>Background:
Bilateral simultaneous angle closure glaucoma is a rare entity. To our knowledge this is the first reported case of bilateral acute angle-closure glaucoma secondary to isolated microspherophakia in an adult.Case presentationA 45-year-old woman presented with bilateral acute angle closure glaucoma, with a patent iridotomy in one eye. Prolonged miotic use prior to presentation had worsened the pupillary block. The diagnosis was not initially suspected, and the patient was subjected to pars-plana lensectomy and anterior vitrectomy for a presumed ciliary block glaucoma. The small spherical lens was detected intraoperatively, and spherophakia was diagnosed in retrospect. She had no systemic features of any of the known conditions associated with spherophakia. Pars-plana lensectomy both eyes controlled the intraocular pressure successfully.
Conclusion:
This case demonstrates the importance of considering the diagnosis of isolated microspherophakia in any case of bilateral acute angle closure glaucoma. Lensectomy appears to be an effective first-line strategy for managing these patients.</description>
			<link>http://www.biomedcentral.com/1471-2415/6/29</link>		
			<dc:creator>Sushmita Kaushik, Nishant Sachdev, Surinder Singh Pandav, Amod Gupta and Jagat Ram</dc:creator>
			<dc:source>BMC Ophthalmology 2006, 6:29</dc:source>
			<dc:subject>Number of accesses: 197</dc:subject>
			<dc:date>2006-07-07</dc:date>
			<dc:identifier>doi:10.1186/1471-2415-6-29</dc:identifier>
			
			
							
					<prism:publicationName>BMC Ophthalmology</prism:publicationName>
					
			
							
					<prism:issn>1471-2415</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>29</prism:startingPage>
					
			
							
					<prism:publicationDate>2006-07-07</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2415/8/13">
            
            <title>Assessment of stereoscopic optic disc images using an autostereoscopic screen &#8211; experimental study</title>
			<description>Background:
Stereoscopic assessment of the optic disc morphology is an important part of the care of patients with glaucoma. The aim of this study was to assess stereoviewing of stereoscopic optic disc images using an example of the new technology of autostereoscopic screens compared to the liquid shutter goggles.
Methods:
Independent assessment of glaucomatous disc characteristics and measurement of optic disc and cup parameters whilst using either an autostereoscopic screen or liquid crystal shutter goggles synchronized with a view switching display. The main outcome measures were inter-modality agreements between the two used modalities as evaluated by the weighted kappa test and Bland Altman plots.
Results:
Inter-modality agreement for measuring optic disc parameters was good [Average kappa coefficient for vertical Cup/Disc ratio was 0.78 (95% CI 0.62&#8211;0.91) and 0.81 (95% CI 0.6&#8211;0.92) for observer 1 and 2 respectively]. Agreement between modalities for assessing optic disc characteristics for glaucoma on a five-point scale was very good with a kappa value of 0.97.
Conclusion:
This study compared two different methods of stereo viewing. The results of assessment of the different optic disc and cup parameters were comparable using an example of the newly developing autostereoscopic display technologies as compared to the shutter goggles system used. The Inter-modality agreement was high. This new technology carries potential clinical usability benefits in different areas of ophthalmic practice.</description>
			<link>http://www.biomedcentral.com/1471-2415/8/13</link>		
			<dc:creator>Maged S Habib, James A Lowell, Nick S Holliman, Andrew Hunter, Daniella Vaideanu, Anthony Hildreth and David HW Steel</dc:creator>
			<dc:source>BMC Ophthalmology 2008, 8:13</dc:source>
			<dc:subject>Number of accesses: 193</dc:subject>
			<dc:date>2008-07-23</dc:date>
			<dc:identifier>doi:10.1186/1471-2415-8-13</dc:identifier>
			
			
							
					<prism:publicationName>BMC Ophthalmology</prism:publicationName>
					
			
							
					<prism:issn>1471-2415</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>13</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-23</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
	<cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
